Inhibitory Effects of Ketoconazole on the Oxidation of Linoleic Acid Micelles, Phospholipid Liposomes, and Human Low Density Lipoprotein (h-LDL) by Munroe, Melissa E.
A Thesis Presented to 
The College of Arts and Sciences 
Drake University 
Ln Partial Fulfillment 
of the Requirements for the Degree 
Master of Arts 
' INHIBITORY EFFECTS OF KETOCONAZOLE ON THE 
OXIDATION OF LINOLEIC ACID MICELLES, 
PHOSPHOLIPID LIPOSOMES, AND HUMAN LOW DENSITY 
LIPOPROTEIN (H-LDL) 
by 
Melissa E. Munroe 
July 1993 
INHIBITORY EFFECTS OF KETOCONAZOLE ON THE OXIDATION 
OF LINOLEIC ACID MICELLES, PHOSPHOLIPID LIPOSOMES, AND 
HUMAN LOW DENSITY LIPOPROTEIN (H-LDL) 
by 
Melissa E. Munroe 
Approved by Committee 
INHIBITORY EFFECTS OF KETOCONAZOLE ON THE OXIDATION OF 
LINOLEIC ACID MCELLES, PHOSPHOLIPID LIPOSOMES , AND HUMAN LOW 
D E N S M  LIPOPROTEIN (H-LDL) 
An abstract of a Thesis by 
Melissa E. Munroe 
July 1993 
Drake University 
Soybean lipoxygenase (SLO) (500-5000 unitslrnl), Fe(III)Cl3/ascorbate (5- 100pM) 
and hematin (5- 100pM) induced oxidative modification of lipids present in rnicelles of 
linoleic acid (0.5 mM), liposomes prepared from phospholipid extracts of bovine brain (2.5 
mglrnl), and h-LDL (0.5 mglrnl). Oxidation of the lipid substrates was determined by the 
formation of thiobarbituric acid reactive substances and conjugated dienes. Free iron 
(Fe(III)C13/ascorbate) was the strongest initiator, followed by hematin and SLO. 
Ketoconazole (KC) attenuated lipid oxidation in a concentration dependent manner at 
pharmacologically relevant levels (25-100~M) in all three substrates. Pretreatment of 
liposomes and h-LDL with KC produced greater attenuation of lipid oxidation by the 
various initiators in comparison to free KC. 
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lNTRoDUCTION AND REVIEW OF THE LITERATURE 
Experimental and 
studies have shown that elevated levels of low-densiv 
lipoprotein (LDL) in plasma significantly contribute to premature atherosclerosis. 
One of the most prevalent causes of morbidity and mortaliv in man, is due 
overaccumulation of lipids, mostly free and esterified cholesterol, in the form of LDL 
entering the arterial intima, the site of atherogenesis. The failure of the cholesterol to retreat 
back from the intima into the circulation on high density lipoprotein m ~ )  panicles results 
in the eventual formation of fatty streaks. Affected sites in the intima accumulate 
cholesterol early in the atherosclerotic process in structures known as atheromas, formed as 
consequence of the disturbed cholesterol flow through the intima caused by an imbalance 
between influx and efflux of lipoproteins (Vance and Vance 1991). 
These atheromas are made up of foamy droplets that create a fatty-streak. The earliest 
recognized gross lesion in atherosclerosis is the fatty streak, characterized by an 
accumulation of "foam" cells loaded with cholesterol esters just beneath the endothelium. 
Most foam cells arise from circulating monocytes/macrophages that have taken up residence 
beneath the vascular endothelium, although some are derived from medial smooth-muscle 
cells (Steinberg et al. 1989). The trapping of foam cells in the innermost layer of the artery 
wall in addition to the release of growth factors and chemoattractants is thought to initiate 
and perpetuate proliferation of smooth muscle cells and deposition of components of 
connective tissue that form the advanced atherosclerotic plaque (Sparrow et al. 1988). 
Circulating monocytes/macrophage~ contain "scavenger receptors'' which are specific 
sites for the of LDL. Significantly, the intima1 monoc~te-macro~hages are 
transformed inlo the characteristic lipid-filled foam cells found in hulllan atherosclerotic 
lesions (vance and Vane- 1991). However. before the "scavenger receptors" can take up 
[he L-,L and the formation of foam cells, the LDL must be 0xidativelY modified 
(Carew 1989). Isolated macrophages have few LDL receptors and fail to take up native 
LDL; however, LDL chemically modified in vitro into acetylated LDL or oxidized LDL. is 
avidly bound and taken by macrophages (Vance and Vance 1991). Oxidative 
modification of the lipoprotein has been shown to render it chemotactic to macrophages and 
cytotoxic to endothelid and arterial smooth muscle cells. Additional macrophages are 
recruited and subsequently circulated to the subendothelial space and within the arterial 
where further modification occurs to form advanced lesions or "plaqueso'. 
There are several possible pathways of oxidative modification (Figure 1). These 
pathways can originate from two sources: within the cell itself and from the surrounding 
media or cytoplasm. Cells may induce oxidation in any of three pathways. In one, the 
lipids in the cell are oxidized first, after which they transfer into the LDL in the medium and 
initiate chain reactions that oxidize the lipids in the LDL extensively. A second pathway 
could involve the direct oxidation of LDL lipids during LDL-cell contact. A third pathway 
postulates the generation of superoxide anion (or other activated oxygen) within the cell, 
followed by release into the medium, where the oxidation of LDL lipids then occurs 
(Steinberg et al. 1989). Cell-mediated oxidation can come from two sources: endothelial 
cells or smooth muscle cells within the arterial intima. During its incubation with cells, the 
LDL particle undergoes a large number of structural changes that alter its metabolism in 
important ways. 
All these changes depend on a common initiating step--the peroxidation of 
polyunsa[urated fatty acids in the LDL lipids (Steinberg et al. 1989). It has been proposed 
that the modification of LDL in endothelial cells involves radical-initiated LDL peroxidation 
(Steinbrecker 1988) Ini[iaton of such modification may include femtin (an iron containing 
structure). hydrolytic enzymes (involved in a number of metabolic processes), cytochrome 
P450 enzymes (invol\rcd in steroid production). or as additionally suggested b!' S. 
Pmhaswathy ;,I. ( 1989). lipoxygenase. Endothelid cells may initiate lipid peroxidation. 
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as mediated superoxide ion (or by other substances that can also transfer electrons to 
transition meta1 ions. The superoxide ion appears to be the significant mediator, as in the 
enzyme superoxide dismutase, which catalyzes the formation of hydrogen peroxide from 
superoxide, is consistently inhibitory (26). 
~cco rd ing  to Morel et al. (1984), events vascular smooth muscle cells are similar to 
those in endothelial cells. Heinecke (1988) clarifies this assumption by indicating that 
extracellular superoxide generation and LDL modification by arterial smooth muscle cells in 
culture are dependent on the presence of sulfur containing amino acids such as L-cystine in 
the incubation medium. Furthermore, LDL modification, but not superoxide generation, 
also requires the presence of micromolar concentrations of transition metals such as Cu(It) 
or Fe(II1). It has been additionally proposed by Cathcart et al. (1988) that 
monocytes/macrophages can further modify LDL after trapping it into the intima in similar 
fashlon to that of endothelial and smooth muscle cells. 
Many pathways of noncellular modification of LDL have been suggested. Sparrow et 
a]. (1988) have proposed that oxidation of LDL can be mimicked by using soybean 
lipoxygenase (SLO), a 15-lipoxygenase. It appears that the 15-lipoxygenase is the most 
prevalent type of lipoxygenase that can catalyze the oxygenation of unsaturated fatty acids 
attached to phospholipids to render them chemotactic to monocytes and cytotoxic to all cells 
(Henriksen 1993). However, the optimal substrate for SLO is not LDL, but rather linoleic 
acid micelles (Ford-Hutchinson 1991). Another substrate which has been successfully 
applied to peroxidation studies and provides an ideal model system as an oxidizable 
substrate and an organized lipid membrane bilayer is ox-brain phospholipid liposomes 
(Carew 1989) Figure 2 illustrates the basic structures of these three substrates used in this 
study. 
Oxidation of lipid substrates may also involve iron (In) chloride/ascorbate. a free iron 
moiety. and hematin, containing a heme-like iron Iron (In) chloridelascorbate has been 
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shown to be an oxidant of phospholipid liposomes (Wiseman et al., 1991). Hematin has 
been shown to oxidize linoleic acid, launching funher oxidation from the auto-oxidation 
already occurring in the micelle (Dix and Marnett 1985). It has been suggested that hernin, 
an analog of hematin with a heme-like iron, is capable of modifying LDL (Bella et al. 
1991). These iron moieties can be found outside of the cell and would work well to 
complement the active non-heme iron moiety of lipoxygenase. It has been proposed that in 
linoleic acid, the lipoxygenase iron goes from the iron(m) to the iron(m state as linoleic 
acid is oxidized to a pentadienyl radical intermediate (Folcik and Cathcan 1993). 
Interventions that block oxidative modification of LDL are under intensive 
investigation. Of interest is the inhibition of lipid oxidation by antioxidants and metal 
chelating agents. The free-radical quenching antioxidants such as butylated hydroxytoluene 
(BHT) and vitamin E have been shown to inhibit LDL oxidation. The drug probucol, 
similar in structure to BHT, is showing some promise as an antioxidant as well (Steinberg 
and Witelum 1990). Agents such as ketoconazole that inhibit cytochrome P-450 enzymes 
are of additional interest as inhibitors of enzyme-induced oxidation. Ketoconazole is 
currently marketed as an antifungal drug and is a known cytochrome P-450 enzyme 
inhibitor . It has been recently reported by Wiseman et al. (1991) that ketoconazole may be 
considered an antioxidant in that it is capable of inhibiting the oxidation of liposomes when 
under oxidative attack by iron(lU) chlorideJascorbate. In clinical investigations, it has been 
further demonstrated by Gylling et al. (1993) that ketoconazole greatly reduces the level of 
cholesterol precursors and low density lipoprotein when taken orally (400 mglday for 5 
weeks). 
The purpose of this study is to determine the antioxidant nature of ketoconazole in 
conjunction with SLO, iron (110 chloride/ascorbate, and hematin. The lipid substrates to be 
used are linoleic acid micelles. phospholipid liposomes, and LDL. While this drug may 
act as a chelating agent to prevent iron moieties from attachng lipids and therefore inhibit 
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oxidative modification, it is also possible that ketoconazole acts to protect the lipid 
membrane shell from oxidative attack either by surrounding the lipid particle or 
incorporating itself directly into the membrane. 
MATERIALS AND METHODS 
Linoleic Acid Preparation (Micelles) 
Linoleic acid (50~1), obtained from Sigma Chemical Company (St. Louis, Mo.), was 
added to 5 0 ~ 1  of 95% ethanol and vortexed in a micmfuge tube. The emulsion (100~1) 
was added to 49.9I-d distilled water (lOmM linoleic acid), vortexed further, and diluted to a 
concentration of 0.5rnM in chelated (using ~helexloo resin from Bio-rad) phosphate 
buffered saline (PBS), pH 7.4 (containing 140mM NaCl, 2.7rnM KC1, 16mM Na2HP04, 
and 2.9mM KH2P04) or in bis-tris propane buffer (BTP), 0.2M for pH studies. 
Ox-Brain Phospholipid Preparation (Liposomes) 
Liposomes were prepared according to the method of Helen Wiseman et al. (1991) 
and Gutteridge (1977). Ox-brain phospholipid (fraction V) was obtained from Sigma 
Chemical Company (St. Louis, Mo.) and dissolved in chloroform to give a final 
concentration of 5 rnglml. The chloroform was evaporated under a stream of nitrogen at 
room temperature. The residue was then resuspended in chelated PBS at the original 
volume and vortexed for 5 minutes in the presence of glass beads. The resulting liposomes 
were left to stand for one hour at 4°C prior to use. 
Human Low-density Lipoprotein (LDL) Preparation 
LDL was isolated from pooled normal human plasma (obtained from the Blood Center 
of Central Iowa) using density gradient ultracentrifugation according to the protocol of 
Radding and Steinberg (1960). The isolated LDL was put under nitrogen and stored in the 
dark at 4OC. 
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Proteinlphospholipid determination of LDL 
Bicinchoninic acid (BcA) protein assay kit was obtained from Sigma and used for 
protein determination of LDL- A standard curve was prepared using various concentrations 
of bovine serum Fraction V (BSA) and working reagent in a 2 0 0 ~ 1  reaction 
mixture on a microtiter plate. LDL reaction mixtures were similarly prepared; all the 
reaction mixtures were incubated at 37'C for 30 minutes. An absorbance reading was 
taken at 562 nm- The protein content of the LDL sample was determined according to the 
standard curve- Phos~holipid content was taken to be equal to protein content (Lehninger 
et al. 1993). 
Soybean Lipoxygenase (SLO) Preparation 
SLO was obtained from Sigma Chemical Company (St. Louis, Mo.) and stored at 
10,000 unitslrnl in ice-cold borate buffer (0.2M), pH 9.0. One SLO unit will cause an 
increase in A234 of 0.001 per minute at pH 9.0 at 2S°C, when linoleic acid was used as 
substrate. Reaction Volume = 3.0 ml (1 cm light path). The unit definition is in 
accordance to Sigma. 
Iron (111) Chloride/Ascorbate and Hematin Preparation 
Stock Iron (HI) chloride and ascorbate solutions (IrnM) were prepared in distilled 
water and distributed in 1:1 molar ratios in all reactions with lipid substrates. Stock 
solutions of hematin (1mM) were w m e d  in distilled water until the hematin was dissolved 
and aliquoted appropriately in all reactions with lipid substrates. 
Ketoconazole (KC) 
Ketoconazole was used in free form (0- 100pM) in all three substrates and directly 
incorporated into liposomes and LDL. In liposomes, ketoconazole was dissolved in 
chloroform and incorporated into the phospholipid (in a mole:mole ratio) before nitrogen 
evaporation of the chloroform and subsequent liposome formation . In LDL* ketoconazo1e7 
dissolved in ethanol, was incubated at 37OC on a m0le:mole ratio with phospholipid 
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for 6 hours. The remaining free ketoconazole was then dialyzed away for 18 houn  in 
chelated PBS (pH 7.4) at 4°C. 
Thiobarbituric Acid Reactive Substances Assay (TBARS) 
The reaction samples were analyzed for the amount of malondialdehyde (MDA) 
equivalents based on the mARS assay as described by Morel et al. (1984). One ml of the 
reaction mixture was combined with 1 ml of 1.26% trichlomacetic acid (TCA) and 1 ml of 
25% thiobarbituric acid (TBA). T h s  reaction was heated for 45 minutes at 95°C. After 
cooling, the samples were read at an absorbance of 532 nm. An increase in absorbance 
readings in comparison to auto-oxidation indicates an increase in the oxidation of the lipid 
substrate. A stzindard curve was prepared using 1,1,4,4 tetramethoxy propane. 
Conjugated Diene Formation 
When linoleic acid is oxidized with SLO or hematin, fatty acid hydroperoxides are 
formed containing conjugated double bonds, showing a UV absorption maximum at 234 
nm. The conjugated lipid hydroperoxides are labile intermediates and decompose to a great 
variety of products. When ,4234 measurements are taken directly after initiation of 
oxidation, the increase of the diene absorption is always preceded by a lag phase during 
which the 234-nm absorption remains constant. Thereafter, the 234-nm absorption rapidly 
increases (propagation period). It was during the propagation period that an accurate 
change in 234-nm absorption was determined and comparative amount of oxidation 
ascertained (Gebicki et al. 1991). Conjugated diene formation can be readily seen in 
linoleic acid oxidation and therefore monitoring UV absorbance values at 234 nm was ideal 
for monitoring the progress of oxidative modification. Oxidation was expressed in a 
change of A234minute. 
Reaction Conditions for Oxidation of Lipid Substrates 
When the thiobarbituric reactive substances assay (TBARS) was to be used. prepared 
linoleic acid micelles (0.5mM). ox-brain phospholipid liposomes (2.5 mg/mli. and LDL 
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(0.5 mg proteidml), in PBS (pH 7.4) were oxidized at 37OC with SLO (500-5000 units). 
iron (111) chloridelascorbate (5-100p.M), and hematin (5-1OOpM). Subsequent data was 
normalized for comparison. 
When conjugated diene formation was to be measured at an absorbance of 234 nm, 
linoleic acid micelles (0.5mM) were oxidized with SLO (1000 units) or hematin (5-50pM) 
at room temperature, and readings were taken immediately. 
RESULTS 
It has been previously shown that linoleic acid rnicelles (Ford-Hutchinson, 1991). 
phospholipid liposomes (Wiseman et al, 1991), and LDL (Cathcart, 1991) are all readily 
oxidizable substrates that can be monitored with the TBARS assay. At physiological 
temperature and pH, oxidation was achieved in all three substrates by all three initiators. 
As shown in figure 3, linoleic acid micelles, phospholipid liposomes, and LDL were 
treated with soybean lipoxygenase (SLO) (5000 units), iron (111) chloridelascorbate 
(SOpM, 1: I ) ,  and hematin (50~M).  Data from these experiments were normalized for 
comparison. All underwent oxidation. Iron (III) chloridelascorbate oxidized the three lipid 
substrates the most rapidly followed by hematin. SLO at pH 7.4 was much less effective. 
Linoleic acid was most readily oxidized, followed by LDL. Phospholipid was much 
slower to react. 
As suggested by Ford-Hutchinson (1991), the optimal pH for SLO is not 
physiological (pH 7.4) but rather about pH 9. Figure 4 shows that while it was possible to 
achieve oxidative modification of linoleic acid (0.5 mM) by SLO at pH 7.4 (as compared to 
the auto-oxidation control), there was greater activity between pH 8.5 and 9.0. Figure 5 
demonstrates that KC (in "free" form) was able to attenuate linoleic acid oxidation by SLO 
(1000 units) both at physiological and optimal pH ranges for the enryme. ~t 
Figure 3. Oxidation of lipids with SLO, iron (III)/ascorbate, and hematin. 
Linoleic acid micelles, phospholipid liposomes, and LDL were oxidized with the initiaors 
SLO, FeC13/ascorbate, and hematin at the indicated concentrations. The initiators were 
added to the lipid substrates in PBS, pH 7.4 at 37°C. The extent of oxidation was 
measured via the TBARS assay as described in Materials and Methods. Data points 
represent the mean values of triplicate samples with SE < 6%. 
Oxidation (moles  MDAlsubstratelhr) 
Figure 4- The effects of soybean lipoxygenase oxidation on linoleic acid micelles. 
Linoleic acid micelles (0.5mM) were oxidized with SLO at room temperature at the 
indicated concentration. SLO was added to rnicelles in 0.2M BTP buffer (pH 7.4-9.5). 
Conjugated diene formation of the fatty acid was monitored during linoleic acid oxidation 
through UV absorbance readings at 234 nm taken every 10 seconds for 4 minutes. The 
extent of oxidation was calculated as a change in A234min. Initiated oxidation of SLO 
was compared to that of auto-oxidation (control). Data points represent the mean values of 
triplicate samples with SE < 2%. 
Linoleic Acid Oxidation 
(Change in A234lmin) 
Figure 5. Effects of ketoconazole (KC) on oxidation of 0.5mh4 linoleic acid by 
SLO. Linoleic acid rnicelles (in BTP buffer) were oxidized with SLO at the indicated 
concentration at room temperature. SLO and KC (0-100pM) were added to micelles in 
0.2M BTP buffer (pH 7.4 and 8.6). Conjugated diene formation of the fatty acid was 
monitored during linoleic acid oxidation through UV absorbance readings at 234 nm taken 
every 10 seconds for 4 minutes. Control (auto-oxidation) samples contained no SLO or 
KC. Data points represent the mean values of triplicate samples with SE < 2.2%. 
Linoleic Acid Oxidation 
(Change A234lmin .) 
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levels (>25~M), KC was able to reduce oxidation greater than 50% at pH 
8.6. 
On the other hand, as seen in figure 6, KC at dosages equal to or less than 25pM was 
able to attenuate linoleic acid oxidation by SLO (1000 units), hematin ( 5 w ) ,  and iron 0 
chloridelascorbate (IOpM, 1: 1) at pH 7.4. Hematin and SLO initiated oxidation of linoleic 
acid at physiological pH was lowered to the level of control (auto-oxidation) by KC at 
25pM while FeC13/ascorbate induced oxidation of linoleic acid was reduced to 50% of the 
non-drug treated samples. 
Phospholipid liposomes have been previously shown to be susceptible to oxidative 
attack by iron (111) chloride/ascorbate (Wiseman, 1991). The experiments represented in 
Figures 7 and 8 reconfirmed this (with 50pM FeC13lascorbate) and showed that the 
liposomes were able to be oxidatively modified by SLO (5000 units) and hematin (50pM), 
although the free iron was comparatively the strongest initiator. In these experiments 2.5 I 
rnglrnl of phospholipid was used for oxidative purposes and the antioxidant effects of KC 
were observed. 
Figure 7 demonstrated that 25pM KC in free (nonincorporated) form was able to 
reduce oxidation of phospholipid liposomes at or greater than 50% of initiated oxidation by 
SLO, FeC13/ascorbate, and hematin. This attenuation continued as the concentration of KC 
was increased to 100pM. Furthermore, the data presented in figure 8 clearly shows a 
stronger antioxidant effect of KC when the drug was directly incorporated into the 
liposomes before they were exposed to oxidative attack by the various initiators. 
Incorporated on a molar basis with phospholipid. KC was able to inhibit phospholipid 
oxidation more effectively and at much lower dosages (10-4 moles 
ketoconezole:phospholipid (KC:PL) incorporated into the liposome is equivalent to a 
0. IkM dose of KC in unincorporated form). 
Figure 6. Effects of ketoconazole on linoleic acid rnicelle oxidation. Linoleic acid 
micelles (0.5mM) were oxidized with initiators SLO, hematin, and FeC13lascorbate at the 
indicated concentrations. The initiators and KC (0-25pM) were added to micelles in PBS, 
pH 7.4. After 3 minutes at 37OC, the reaction was terminated and assayed for TBARS as 
described in Materials and Methods. Control samples contained no initiators or KC. Data 
points represent the mean values triplicate samples withn SE < 6%. 
Effects of ketoconazole on 
linoleic acid micelle oxidation 
Figure 7. Effects of ketoconazole on oxidation of ox brain phospholipid 
liposomes. Phospholipid liposomes (2.5mglml) were oxidized with initiators SLO, 
hematin, and FeClyascorbate at the indicated concentrations. The initiators and KC (O- 
100pM) were added to liposomes in PBS, pH 7.4. After 20 minutes at 37OC, the reaction 
was terminated and assayed for TBARS as described in the Materials and Methods. 
Control samples contained no initiators or KC. Data points represent the mean values of 
triplicate samples with SE < 6.2%. 
Phospholipid Oxidation 
(nmol MDAImg Phospholipid) 
Figure 8. Effects of incorporated ketoconazole on oxidation of ox brain 
phospholipid liposomes. Phospholipid liposomes (2.5 mg/ml) were oxidized with 
initiators SLO, FeC13/ascorbate, and hematin at the indicated concentrations. KC was 
incorporated into the liposomes prior to oxidation on a mole to mole basis of phospholipid 
content. Initiators were added to liposomes in PBS, pH 7.4. After 20 minutes at 37"C, 
the reaction was terminated and assayed for TBARS as described in Materials and 
Methods. Control samples contained no initiators or KC. Data points represent the mean 
values of triplicate samples with SE < 3%. 
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ü em at in's oxidative action on phospholipid liposomes was almost completely arrested 
when moles KC:PL was first incorporated into the liposome. Any further 
incorporation of KC into the liposome revealed no additional protection. SLO was 
inhibited by 50% at approximately moles KC:PL incorporation as compared to a 
dosage of 20pM KC in unincorporated form (figure 7). Complete inhibition was achieved 
by 10-1 moles KC:PL incorporation (100p.M free KC). As with unincorporated KC. 
incorporated KC into the liposome attenuated liposome oxidation by free iron 
\ - \ (~eClg/ascorbate) in a concentration dependent manner. Again, incorporated KC was more 
effective at lower dosages than unincorporated KC. Incorporation of KC into the liposome 
prior to liposome oxidation revealed a ten fold decrease in the dosage required to produce 
the same inhibitory effects as nonincorporated KC. 
A greater difference between the effects of unincorporated versus incorporated KC on 
the oxidation of LDL was demonstrated in figures 9 and 10. It was shown in figure 9 that 
while LDL oxidation by SLO was inhibited by nonincorporated KC, the oxidative effects 
of free iron and hematin on LDL were not greatly reduced. However, as figure 10 
clearly demonstrates, when KC is incorporated into LDL particles as a pretreatment, 
inhibition of lipid oxidation by the various initiators was both concentration dependent and 
greater than 506 .  SLO's action on LDL was completely attenuated when 10-3 moles 
KC:PL was incorporated into LDL ( equivalent to 1pM free KC--see figure 9). As the 
amount of KC incorporated into LDL was increased, greater attenuation was achieved 
below the level of auto-oxidation. Oxidation of LDL by hematin was reduced 50% by 
pretreating LDL with 10-2 moles KC:PL (equivalent to lOpM free KC). lnhibition 
continued as more KC was incorporated. Free iron's action on LDL was equally inhibited 
by incorporn[ed KC, showing 50% inhibition with moles KC:PL incorporation and 
66% inhibition when 1 mole KC:PL was incorporated into LDL. 
Figure 9. Effects of ketoconazole on oxidation of human LDL. Isolated human 
LDL (0.5 mg proteinlml) was oxidized with initiators SLO, hematin, and FeC13lascorbate 
at the indicated concentrations. The initiators and KC (0-100p.M) were added to LDL in 
PBS, pH7.4. After 24 hours at 37"C, the reaction was terminated and assayed for TBARS 
as described in the Materials and Methods section. Control samples contained no initiators 
or KC. Data points represent the mean values of triplicate samples with SE < 5% 
Effects of ketoconazole on 
oxidation of human LDL 
+ sooo S l . 0  
sOphl I:eC13/Auc1~rl)nlr. 
__(_W)_ 50pM l l r ~ # ~ a t l n  
Figure 10. Effects of incorporated ketoconazole on oxidation of human LDL. 
Isolated human LDL (0.5 mg proteidrnl) was oxidized with initiators SLO, hematin, and 
FeC13lascorbate at the indicated concentrations. KC was incorporated into LDL prior to 
oxidation on a mole to mole basis of phospholipid content. Initiators were added to LDL in 
PBS, pH 7.4. After 24 hours at 3 7 O C ,  the reaction was terminated and assayed for 
TBARS as described in Materials and Methods. Control samples contained no initiators or 
KC. Data points represent the mean values of triplicate samples with SE < 8%. 
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DISCUSSION 
The presented above, in addition to what is already known about the structure 
and reactive nature of linoleic acid micelles, phospholipid liposomes, and LDL, allows for 
a more complete picture of the ability of iron moieties to oxidatively modify LDL and its 
model components. They also allow for theoretical conclusions concerning the way in 
which ketoconazole is able to attenuate such oxidation. 
within the lipid model system, linoleic acid can be considered a component of the inner 
LDL core within the triacylglycemls. Linoleic acid rnicelles, being unilarnellar particles of 
free fatty acid (figure 2), are readily oxidized (figures 3-6). They are converted into 
conjugated dienes and, among other compounds, aldehyde products, malondialdehyde 
being prominent among them (Dix and Marnett 1985). The data (figures 3-6) suggest that, 
of the three iron moieties studied (heme, SLO, and free iron), free iron in the form of 
~ ~ C 1 3 / ~ s c o r b a t e  is he strongest initiator of oxidation in rnicelles because it is not bound to 
anything and therefore can easily fit into the lipid membrane. The iron in hematin, being 
bound similarly to heme, is a successful initiator, but not to the same extent as free iron. 
SLO is not near as successful as an oxidative initiator as hematin and free iron. However, 
as the pH is raised from physiological pH to a level between pH 8.5 and 9.0, the reactivity 
of SLO with linoleic acid micelles reaches an optimum (figures 4 3 ,  suggesting that 
optimal surroundings for oxidative modification of lipids by SLO is at a higher pH than 
physiological. 
Phospholipid liposomes. due to their multilamellar nature (figure 2) are more stable 
than the unilamellar linoleic acid micelles. They require a greater length of time to produce 
comparable oxidative products (figure 3). Because phospholipid creates a monolayer 
around the LDL particle, the phospholipid liposome with its outer boundary built of a 
phospholipid monolayer is an ideal model system for studying the effects of oxidative 
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attack to the outer shell of the lipid membrane. Whlle liposomes are fajrly stable, free iron 
can penetrate the lipid membrane and cause oxidative modification, as indicated by the 
increase in TBAR values (figures 3,7 ,8) .  The iron moieties of hematin and SLO, being 
bound and therefore cumbersome, are not able to penetrate the liposome as easily 
However, prevention is not complete as the liposome is constructed of external hydrophilic 
heads followed by an internal hydrophobic carbon chain similar to that of the linoleic acid 
micelle (figure 2). 
While LDL is not as readily oxidized as linoleic acid due to its more complex smcture 
(figure 2), it is also not as stable as phospholipid liposomes for the same reason. Once 
again, free iron is the strongest initiator of those studied. Hematin, while not as strong 
with its bound iron, is still able to penetrate the unwieldy outer layer of the LDL particle to 
reach the inner core. This phenomenon may also be due to the free (unesterified) 
cholesterol found along the outside of the LDL particle with phospholipid monolayer. It 
may be that disrupting the cholesterol molecules may be enough to disrupt the fluidity of 
the membrane, allowing the hematin to react with the outer phospholipid and inner 
triacylglycerol components. SLO continues to be the weakest initiator (figures 3, 9, lo), 
partly because it is not at optimum pH and partly due to the bound iron moiety that is not 
allowed to react in the manner of hematin. 
While ketoconazole is already a successful antifungal drug, it has shown potential as 
an antioxidant (Wiseman et al. 1991). Ketoconazole was able to inhibit oxidation by all 
three initiators in all three lipid sources. In linoleic acid, ketoconazole was able to inhbit 
the oxidation of SLO at both physiological (pH 7.4) and optimal (pH 8.5-9.0) pH for the 
enzyme (figures 5.6). This was true within the cellular level range (5  25w) (Cathcart et 
a!. 199 I and Eve Zentrich, unpubl.) and enhanced at phmacological levels (>?5p~). 
Hematin and free iron oxidation was attenuated at physiological pH withn the cellular level 
range to at 50% (figure 6). These results indicate that ketoconazole is multifunctional. It is 
that the iron moieties of the initiators are being surrounded (chelated) by 
ketoconazole to Prevent them from interacting with the lipid membrane. It is also likely that 
the 'drug is directly interacting with the lipid membrane itself to protect it from oxidative 
attack. 
It is  suggested by the effect of ketoconazole on the oxidation of phospholipid 
liposomes and LDL that the greater protective action of ketoconazole is its direct association 
with the lipid membrane (figures 7-10). As illustrated in figures 7 and 8, ketoconazole is 
more effective against oxidative attack at lower doses than free KC if it is first incorporated 
directly into the liposome. Free (unincorporated) ketoconazole is able to attenuate the 
oxidation of the initiators equal to or greater than 50% (figure 7). Another line of evidence 
suggesting ketoconazole's protective effect on the membrane of liposome is the fact that 
smaller concentrations of free ketoconazole are able to attenuate oxidative attack by 
relatively higher concentrations of the three initiators. It would seem unlikely that such a 
small amount of drug would be able to chelate such a large amount of iron moiety (figures 
7 and 8). 
This apparent antioxidant action of ketoconazole is further demonstrated in its action 
upon LDL (figures 9 and 10). LDL oxidation by SLO is easily inhibited by free 
(unincorporated) ketoconazole. Ketoconazole either directly protects the particle membrane 
from oxidative attack and/or it blocks the iron moiety of the enzyme. The modifying 
actions of hematin and free iron on LDL are not easily attenuated by free KC (figure 9). 
However, when LDL is pretreated with ketoconazole so that the drug is incorporated 
directly into the lipid membrane, only micromolar amounts of ketoconazole are required to 
block the action of hematin and free iron Due to the concen~ation-dependent manner in 
which attenuation of oxidation is achieved by incorporated ketoconazole, i t  is possible that 
the modifying action hematin and free iron on LDL can be totally blocked with the proper 
~h;lrmncological dosage of KC (figure 10). 
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It is suggested by this study that ketoconazole, as an antioxidant, acts primarily to 
protect the lipid membrane from oxidative attack and perhaps has a minor role in chelating 
iron moieties. Future studies involving spectroflurornetry (inserting a tumbling flur into the 
lipid membrane to look at its fluid properties) could shed more light on this matter. Clinical 
studies considering the effect of ketoconazole on patients with hypercholesterolemia show a 
significant decrease in the plasma levels of cholesterol precursors and LDL (Gylling et al. 
1993), further suggesting that ketoconazole may be an already existing drug that can limit 
the adverse effects of atherosclerosis. 
3 3 
CONCLUSIONS 
1. Linoleic acid micelles, phospholipid liposornes, and LDL were oxidized by the 
initiators SLO, free iron, and hemati (figure 3). Linoleic acid micelles were oxidized by 
SLO at its optimum pH, pH 8.5-9.0 (figure 4). 
2. Free (unincorporated) KC, at 25-100w, attenuated lipid oxidation (figures 6, 7, 
9). Free KC also attenuated linoleic oxidation by SLO at pH 8.6 (figure 5). 
3. Oxidation of phospholipid liposomes and LDL by the various initiators was 
inhibited by KC more effectively if KC was incorporated into the lipid substrate prior to 
oxidative attack (figures 8,10) . 
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